{
    "eid": "2-s2.0-85089227432",
    "title": "Effect of drug metabolizing enzymes and transporters in Thai colorectal cancer patients treated with irinotecan-based chemotherapy",
    "cover-date": "2020-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Multidisciplinary",
            "@code": "1000",
            "@abbrev": "MULT"
        }
    ],
    "keywords": [],
    "authors": [
        "Chalirmporn Atasilp",
        "Phichai Chansriwong",
        "Ekaphop Sirachainan",
        "Thanyanan Reungwetwattana",
        "Suwannee Sirilerttrakul",
        "Monpat Chamnanphon",
        "Apichaya Puangpetch",
        "Chonlaphat Sukasem"
    ],
    "citedby-count": 15,
    "ref-count": 41,
    "ref-list": [
        "Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan",
        "Regimen selection for first-line FOLFIRI and FOLFOX based on UGT1A1 genotype and physical background is feasible in Japanese patients with advanced colorectal cancer",
        "Phase III comparison of two irinotecan dosing regimens in second-line therapy of metastatic colorectal cancer",
        "Structural insights into CPT-11 activation by mammalian carboxylesterases",
        "Regioselective metabolism of taxoids by human CYP3A4 and 2C8: Structure\u2013activity relationship",
        "Extensive contribution of the multidrug transporters P-glycoprotein and Mrp1 to basal drug resistance",
        "Pharmacogenetics of uridine diphosphoglucuronosyltransferase (UGT) 1A family members and its role in patient response to irinotecan",
        "Pharmacogenetics of irinotecan metabolism and transport: An update",
        "Clinical pharmacogenetics of irinotecan (CPT-11)",
        "Concurrence of UGT1A polymorphism and end-stage renal disease leads to severe toxicities of irinotecan in a patient with metastatic colon cancer",
        "Clinical significance of UDP-glucuronosyltransferase 1A1*6 for toxicities of combination chemotherapy with irinotecan and cisplatin in gynecologic cancers: A prospective multi-institutional study",
        "Influence of drug transporters and UGT polymorphisms on pharmacokinetics of phenolic glucuronide metabolite of mycophenolic acid in Japanese renal transplant recipients",
        "Irinotecan pathway genotype analysis to predict pharmacokinetics",
        "Association of the P-glycoprotein transporter MDR1(C3435T) polymorphism with the susceptibility to renal epithelial tumors",
        "MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine",
        "Pharmacogenetic analysis of interindividual irinotecan pharmacokinetic variability: Evidence for functional variant of ABCC2",
        "Diflomotecan pharmacokinetics in relation to ABCG2 421C>A genotype",
        "Genotype\u2013phenotype correlations in 5-fluorouracil metabolism: A candidate DPYD haplotype to improve toxicity prediction",
        "Development of pyrosequencing method for detection of UGT1A1 polymorphisms in thai colorectal cancers",
        "UGT1A1*28 genotype and irinotecan-induced neutropenia: Dose matters",
        "Severe irinotecan-induced toxicity in a patient with UGT1A1 28 and UGT1A1 6 polymorphisms",
        "Clinical implications of UGT1A1*28 genotype testing in colorectal cancer patients",
        "UGT1A1 gene polymorphisms and the toxicities of FOLFIRI in Chinese Han patients with gastrointestinal cancer",
        "Distribution of uridine diphosphate glucuronosyltransferase 1A polymorphisms and their role in irinotecan-induced toxicity in patients with cancer",
        "Relevance of different UGT1A1 polymorphisms in irinotecan-induced toxicity: A molecular and clinical study of 75 patients",
        "Association of ABCC2 genotype with efficacy of first-line FOLFIRI in Japanese patients with advanced colorectal cancer",
        "Integrated pharmacogenetic prediction of irinotecan pharmacokinetics and toxicity in patients with advanced non-small cell lung cancer",
        "UGT1A1*6 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japanese cancer patients",
        "Relationship between UGT1A1*6/*28 polymorphisms and severe toxicities in Chinese patients with pancreatic or biliary tract cancer treated with irinotecan-containing regimens",
        "Associations between UGT1A1*6 or UGT1A1*6/*28 polymorphisms and irinotecan-induced neutropenia in Asian cancer patients",
        "Association between the low-dose irinotecan regimen-induced occurrence of grade 4 neutropenia and genetic variants of UGT1A1 in patients with gynecological cancers",
        "Physiological, pharmacological and clinical features of the multidrug resistance protein 2",
        "Single nucleotide polymorphisms in multidrug resistance associated protein 2 (MRP2/ABCC2): Its impact on drug disposition",
        "Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer",
        "Effects of UGT1A1*6, UGT1A1*28, and ABCB1-3435C>T polymorphisms on irinotecan induced toxicity in Chinese cancer patients",
        "UGT1A1 polymorphism can predict hematologic toxicity in patients treated with irinotecan",
        "Transport of 7-ethyl-10-hydroxycamptothecin (SN-38) by breast cancer resistance protein ABCG2 in human lung cancer cells",
        "ABCG2 pharmacogenetics: Ethnic differences in allele frequency and assessment of influence on irinotecan disposition",
        "ABC transporter polymorphisms are associated with irinotecan pharmacokinetics and neutropenia",
        "Metabolism of irinotecan (CPT-11) by human hepatic microsomes: Participation of cytochrome P-450 3A and drug interactions",
        "Undetected toxicity risk in pharmacogenetic testing for dihydropyrimidine dehydrogenase"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60015887",
            "affilname": "Faculty of Medicine Ramathibodi Hospital, Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015887",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199578",
            "affilname": "Ramathibodi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pathum Thani",
            "@id": "60023366",
            "affilname": "Rangsit University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023366",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Ramathibodi Hospital Cancer Center",
        "Mahidol University"
    ]
}